PDS Biotechnology Corporation (PDSB)
NASDAQ
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -31.69 | -49.977 | -63.439 | -27.603 | -65.433 | -34.496 | -56.662 | -62.966 |
Return on Equity (%) | -36.666 | -67.077 | -88.641 | -33.7 | -76.476 | -37.454 | -76.213 | -122.459 |
Return on Invested Capital (%) | -32.82 | -53.763 | -68.928 | -85.418 | -76.759 | -37.463 | -62.255 | -74.11 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 3.087 | 2.021 | 0.949 | 2.215 | 1.219 | 2.222 | 1.458 | 0.84 |
Earnings Per Share | -1.342 | -1.648 | -1.3 | -1.325 | -0.667 | -0.595 | -1.354 | -1.38 |
Cash Per Share | 3.679 | 2.853 | 1.102 | 2.303 | 1.295 | 2.293 | 2.447 | 1.818 |
Working Capital Per Share | 3.481 | 2.468 | 0.931 | 2.211 | 1.216 | 2.217 | 2.209 | 1.46 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -1.406 | -1.731 | -1.388 | -1.398 | -0.667 | -0.753 | -1.394 | -1.426 |
EBITDA Per Share | -1.406 | -1.731 | -1.388 | -1.398 | -0.667 | -0.753 | -1.394 | -1.426 |
Free Cash Flow Per Share | -1.322 | -1.647 | -1.305 | -1.344 | -0.668 | -0.595 | -1.354 | -1.381 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 28,92M | 30,87M | 31,45M | 5,28M | 22,26M | 28,45M | 30,17M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 30,17M | 30,72M | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 64,72M |
Ratio cours/bénéfice | -1,56 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 1,18 |
Ratio prix/valeur comptable | 2,56 |
Rendement de dividende | - |
Actions en circulation | 37,41M |
Volume moyen (1 semaine) | 344,16k |
Volume moyen (1 mois) | 363,87k |
Variation sur 52 semaines | -66,27% |
Plus haut sur 52 semaines | 6,68 |
Plus bas sur 52 semaines | 1,53 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales